The overall goal of this research is to characterize the process of biologic calcification. This proposal examines the mechanism of membrane-mediated proteolipid-dependent calcium hydroxyapatite (HA) by analyzing matrix vesicle proteolipid (MVP) structure, function, and metabolic regulation, using epiphyseal chondrocyte or odontoblast culture-derived matrix vesicles, matrix vesicles from chick growth cartilage and root incisor dentine, and synthetic proteoliposomes as models. The association of membranes and membrane components, particularly Pr and Ca-phospholipid-Pi complexes (CPLX), with initial HA formation in normal calcifying tissues, osseous induction, and hard tissue repair, as well as in dystrophic calcification, suggests that certain properties of membranes are conducive to HA deposition when sufficient Ca is available. This has important implications in the treatment of diseases like osteoporosis and periodontal diseases as well as for prevention and treatment of ectopic mineral deposits. Recent research indicates that Pr apoprotein structures phospholipid to interact with Ca and Pi to form CPLX and subsequent HA; however, the mechanism of this process is unknown. If the principals of membrane-associated calcification are constant and independent of tissue source, then normal mineral deposition must be regulated by the concentration of a particular apoprotein, and the nature of its phospholipid domain, as well as availability of mineral ions. This research described in this proposal will examine this hypothesis by chemically characterizing MVP (SDS-PAGE; Western blot, proteolytic digest maps, and N- and C- terminal amino acid analyses to determine aproprotein heterogeneity; purification of apoprotein subclasses by HPLC); examining its interaction with membrane lipids to form a calcifiable domain (construction of synthetic proteoliposomes to study protein-protein and protein-lipid interactions in CPLX and/or HA formation), determining whether MVP functions in transmembrane ion transport (H+, Ca++ or Pi transport in proteoliposomes and matrix vesicles), and examining its regulation by hormonal (vitamin D) and nutritional factors (Zn) influencing lipid metabolism. Tissue culture data, obtained in the absence of competing regulatory factors, will be compared to experiments with intact animals to ensure physiologic relevance.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE005937-05
Application #
3219666
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Project Start
1981-03-01
Project End
1987-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
5
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Type
Schools of Dentistry/Oral Hygn
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Kinney, R C; Schwartz, Z; Week, K et al. (2005) Human articular chondrocytes exhibit sexual dimorphism in their responses to 17beta-estradiol. Osteoarthritis Cartilage 13:330-7
Schwartz, Z; Carney, D H; Crowther, R S et al. (2005) Thrombin peptide (TP508) treatment of rat growth plate cartilage cells promotes proliferation and retention of the chondrocytic phenotype while blocking terminal endochondral differentiation. J Cell Physiol 202:336-43
Schwartz, Z; Graham, E J; Wang, L et al. (2005) Phospholipase A2 activating protein (PLAA) is required for 1alpha,25(OH)2D3 signaling in growth plate chondrocytes. J Cell Physiol 203:54-70
Gay, I; Schwartz, Z; Sylvia, V L et al. (2004) Lysophospholipid regulates release and activation of latent TGF-beta1 from chondrocyte extracellular matrix. Biochim Biophys Acta 1684:18-28
Boyan, B D; Schwartz, Zvi (2004) Rapid vitamin D-dependent PKC signaling shares features with estrogen-dependent PKC signaling in cartilage and bone. Steroids 69:591-7
Boyan, B D; Jennings, E G; Wang, L et al. (2004) Mechanisms regulating differential activation of membrane-mediated signaling by 1alpha,25(OH)2D3 and 24R,25(OH)2D3. J Steroid Biochem Mol Biol 89-90:309-15
Boyan, Barbara D; Dean, David D; Sylvia, Victor L et al. (2003) Steroid hormone action in musculoskeletal cells involves membrane receptor and nuclear receptor mechanisms. Connect Tissue Res 44 Suppl 1:130-5
Schwartz, Z; Shaked, D; Hardin, R R et al. (2003) 1alpha,25(OH)2D3 causes a rapid increase in phosphatidylinositol-specific PLC-beta activity via phospholipase A2-dependent production of lysophospholipid. Steroids 68:423-37
Boyan, Barbara D; Sylvia, V L; McKinney, N et al. (2003) Membrane actions of vitamin D metabolites 1alpha,25(OH)2D3 and 24R,25(OH)2D3 are retained in growth plate cartilage cells from vitamin D receptor knockout mice. J Cell Biochem 90:1207-23
Lohmann, C H; Schwartz, Z; Liu, Y et al. (2003) Pulsed electromagnetic fields affect phenotype and connexin 43 protein expression in MLO-Y4 osteocyte-like cells and ROS 17/2.8 osteoblast-like cells. J Orthop Res 21:326-34

Showing the most recent 10 out of 137 publications